We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BEI:XETRBeiersdorf AG Analysis

Data as of 2026-06-13 - not real-time

CN¥3.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Beiqi Foton Motor trades at CNY 3.10, comfortably above its 20‑day SMA (≈CNY 3.06) and 200‑day SMA (≈CNY 2.99) while still sitting beneath the 50‑day SMA (≈CNY 3.28), signaling a neutral‑to‑slightly‑bullish technical stance. MACD has turned bullish with the line crossing above the signal and a small positive histogram, and the stock is seeing increasing volume, suggesting accumulating buyer interest. However, the 30‑day volatility is high at roughly 36 % and the price remains well under the DCF‑derived fair value of about CNY 4.56, indicating room for upside but also heightened short‑term price swings.
Fundamentally, the company posts modest revenue growth of 6.6 % and a solid cash cushion (CNY 10 bn) against its debt (CNY 5.2 bn), but margins are thin (gross margin ≈9.7 %, net margin ≈2.3 %) and ROE is only about 8.6 %. The stock carries no dividend, and its beta is low (~0.36), implying limited market‑wide risk despite the sector’s cyclical nature. Overall, the combination of undervaluation, decent liquidity, and a positive cash position supports a cautiously optimistic outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Bullish MACD crossover with rising volume
  • Price above short‑term SMA and below 50‑day SMA offering upside potential
  • High short‑term volatility suggests active trading opportunities

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant undervaluation versus DCF fair value
  • Positive free cash flow and strong cash‑to‑debt balance
  • Steady revenue growth in a recovering commercial‑vehicle market

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Exposure to regulatory shifts toward electric and low‑emission vehicles
  • Thin profit margins and modest ROE limit long‑term earnings acceleration
  • Low beta and solid liquidity mitigate broader market risk

Key Metrics & Analysis

Financial Health

Revenue Growth6.60%
Profit Margin2.30%
P/E Ratio17.2
ROE8.59%
ROA0.62%
Debt/Equity31.24
P/B Ratio1.5
Op. Cash FlowCN¥1.3B
Free Cash FlowCN¥1.8B

Technical Analysis

TrendNeutral
RSI47.4
SupportCN¥2.90
ResistanceCN¥3.37
MA 20CN¥3.06
MA 50CN¥3.28
MA 200CN¥2.99
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥4.56
GradeUndervalued
TypeValue

Risk Assessment

Beta0.36
Volatility36.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.